Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wenyan Shen is active.

Publication


Featured researches published by Wenyan Shen.


Neurobiology of Disease | 2002

Polyglutamine repeat length-dependent proteolysis of huntingtin.

Banghua Sun; Wei Fan; Aldona M. Balciunas; Jillian K. Cooper; Gal Bitan; Shirley Steavenson; Paul Denis; Yunjen Young; Beverly S. Adler; Larry Daugherty; Raffi Manoukian; Gary Elliott; Wenyan Shen; Jane Talvenheimo; David B. Teplow; Mitsuru Haniu; Raj Haldankar; Christopher A. Ross; Martin Citron; William G. Richards

Amino-terminal fragments of huntingtin, which contain the expanded polyglutamine repeat, have been proposed to contribute to the pathology of Huntingtons disease (HD). Data supporting this claim have been generated from patients with HD in which truncated amino-terminal fragments forming intranuclear inclusions have been observed, and from animal and cell-based models of HD where it has been demonstrated that truncated polyglutamine-containing fragments of htt are more toxic than full-length huntingtin. We report here the identification of a region within huntingtin, spanning from amino acids 63 to 111, that is cleaved in cultured cells to generate a fragment of similar size to those observed in patients with HD. Importantly, proteolytic cleavage within this region appears dependent upon the length of the polyglutamine repeat within huntingtin, with pathological polyglutamine repeat-containing huntingtin being more efficiently cleaved than huntingtin containing polyglutamine repeats of nonpathological size.


Archive | 2005

Antibodies to DKK-1

Ji Li; Wenyan Shen; Hsieng S. Lu; William Gleason Richards


Archive | 2006

Sclerostin binding agents

Christopher Paszty; Martyn Kim Robinson; Kevin Graham; Alistair James Henry; Kelly Sue Hoffmann; John Latham; Alastair Lawson; Hsieng S. Lu; Andy Popplewell; Wenyan Shen; David Winkler; Aaron George Winters


Archive | 2008

Homogeneous antibody populations

Thomas M. Dillon; Pavel V. Bondarenko; Martin J. Allen; Alain Balland; Margaret Speed Ricci; Amy Guo; Wenyan Shen; Jeonghoon Sun; Chris Vezina


Archive | 2008

Sclerostin binding antibodies

Christopher Paszty; Martyn Kim Robinson; Kevin Graham; Alistair James Henry; Kelly Warmington; John Latham; Hsieng S. Lu; Alastair Lawson; Andy Popplewell; Wenyan Shen; David Winkler; Aaron George Winters


Archive | 2008

Modified lecithin-cholesterol acyltransferase enzymes

Mingyue Zhou; Thomas C. Boone; David Park Meininger; Margit Schwarz; Bei Shan; Wenyan Shen


Archive | 2007

GLP-1 COMPOUND/GLUCAGON ANTIBODY COMPOSITIONS

Wenyan Shen; Kevin Graham; Katherine Ann Winters; Murielle Veniant-Ellison; Thomas C. Boone


Archive | 2009

Treatment methods using Dkk-1 antibodies

Ji Li; Wenyan Shen; Hsieng S. Lu; William Gleason Richards


Archive | 2017

COMPLEJO QUE COMPRENDE UN POLIPÉPTIDO CITOSINA-1 INHIBIDOR DE MACRÓFAGO (MIC-1) TAMBIÉN CONOCIDO COMO GDF15

Hugo Matern; Raj Haldankar; Darrin Anthony Lindhout; Wenyan Shen


Archive | 2014

Modificerede lecithin-kolesterol-acyltransferase-enzymer

Mingyue Zhou; Thomas C. Boone; David Park Meininger; Margrit Schwartz; Bei Shan; Wenyan Shen

Researchain Logo
Decentralizing Knowledge